Physician profile
Sameer Stas
NPI 1871541185
$1,176.29
in general payments reported to CMS, 2019-2025
16 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $116 · 2021: $143 · 2022: $41.52 · 2023: $134 · 2024: $101 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $290.38 | 2019-2025 | Omnipod |
| Abbott Laboratories | $278.10 | 2019-2025 | Freestyle Libre 3 |
| Medtronic Minimed, INC. | $130.05 | 2019-2020 | |
| Dexcom, INC. | $95.73 | 2022-2024 | Dexcom G6 Transmitter |
| Itamar Medical INC | $89.28 | 2021-2024 | Watchpatone |
| Sanofi-Aventis U.S. LLC | $55.00 | 2021 | |
| Radius Health, INC. | $50.56 | 2025 | Tymlos |
| Tandem Diabetes Care, INC. | $39.45 | 2019 | |
| Lifescan, INC. | $26.68 | 2019 | |
| Amgen INC. | $26.14 | 2019 | |
| Beta Bionics, INC. | $21.92 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Novo Nordisk INC | $16.68 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.80 | 2019 | |
| Medtronic, INC. | $14.20 | 2021 | |
| Becton, Dickinson and Company | $14.19 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Stas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.